Position in ABUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,837,408
+$1,031,158 QoQ
Shares Held
2,466,127
+2.7% QoQ
Ownership
1.25%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 175 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. ABUS ranks #36 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in ABUS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,837,408 | 2,466,127 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $10,806,250 | 2,401,389 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $590,478 | 122,761 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $563,762 | 124,177 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $384,660 | 124,486 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $413,205 | 118,397 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $388,125 | 118,693 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $561,318 | 145,797 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $47,116 | 15,248 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $31,754 | 12,308 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $30,770 | 12,308 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $24,985 | 12,308 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $32,331 | 14,057 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $36,959 | 12,198 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $28,421 | 12,198 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $23,298 | 12,198 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $28,362 | 10,466 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $23,693 | 7,951 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $25,382 | 6,525 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $27,992 | 6,525 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $18,910 | 6,241 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||